Pain
May 14, 2008
Array BioPharma Presents Additional Positive Phase 2 Results In...
“We believe these impressive trial results demonstrate the potential of this drug to suppress inflammation and treat signs and symptoms in a wide variety of inflammatory diseases.”
Array BioPharma Inc. announced that its Chief Medical Officer, John Yates, M.D., presented additional positive results from a Phase 2 clinical trial evaluating the efficacy of ARRY-797, a novel small molecule ... via MediLexicon
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Addicted to Pain-Killers? (from Apr '07) | 2 hr | miss | 704 |
| FDA Warns About Cipro, Other Antibiotics | 3 hr | Ty Taylor | 31 |
| House passes bill to temporarily ban new methad... (from Mar '07) | 4 hr | Ruby_Tuesday | 24 |
| What is Ultram? (from Nov '06) | 7 hr | shelly | 233 |
| Opioid Addiction: No Reason to Withhold Pain Ma... | Tue | Ban Methadone | 32 |
| Genital herpes common, but percentage is declining | Tue | this articl... | 11 |
| FDA calls for urgent warning on tendon risks | Jul 21 | mimi | 11 |
Most Popular
